US Stock MarketDetailed Quotes

HAE Haemonetics

Watchlist
  • 77.720
  • 0.0000.00%
Close Jan 7 15:59 ET
  • 76.810
  • -0.910-1.17%
Pre 09:24 ET
3.90BMarket Cap32.25P/E (TTM)

Haemonetics Key Stats

Haemonetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.015M--
--2025/Q3-- / 352.893M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 359.015M--
--2025/Q3-- / 352.893M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--

Unlock Free Earnings Estimates

Haemonetics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    87.50%
  • Hold

    12.50%
  • Sell

    0.00%

Price Target

No Data